Many neuropsychiatric diseases still elude full understanding and effective therapy. It has become increasingly obvious that some of the prevailing explanations of their pathology are overly simplistic since only a small fraction of patients appear to be The complexity of interactions among neurotransmit- ters and neuromodulators in the brain continues to ex- pand. The involvement of immune molecules has added a new dimension. An important new contributor that is of interest to psychopharmacology is a unique cell, named “mast cell” by Paul Erlich in 1887 because its numerous metachromatic granules reminded him of a “well-fed cell” (German